| MVI negative (N = 1462) | MVI positive (N = 235) | p |
---|---|---|---|
Sex (male, ratio) | 1152 (78.80%) | 200 (85.11%) | 0.026 |
Age (years) | 52.09 ± 13.43 | 49.15 ± 11.99 | 0.002 |
HGB (g/L) | 139.16 ± 22.30 | 140.53 ± 21.68 | 0.210 |
WBC (× 109 /L) | 6.48 ± 3.01 | 6.20 ± 2.91 | 0.742 |
PLT (× 109 /L) | 139.65 ± 78.25 | 139.78 ± 76.10 | 0.981 |
NEU (%) | 59.08 ± 18.66 | 63.30 ± 13.62 | 0.001 |
CHB (positive, ratio) | 1102 (75.38%) | 186 (79.15%) | 0.209 |
Serum AFP (≥ 400 ng/mL, ratio) | 500 (34.20%) | 135 (57.45%) | < 0.001 |
TB (µmol/L) | 18.88 ± 6.10 | 17.86 ± 5.06 | 0.588 |
AST (median IU/L) | 45 | 47 | 0.231 |
ALT (median IU/L) | 37 | 39 | 0.373 |
ALB (g/L) | 41.07 ± 6.23 | 40.53 ± 5.40 | 0.215 |
PT (s) | 12.00 ± 1.35 | 11.94 ± 1.45 | 0.588 |
Tumor type (single, ratio) | 1261(86.25%) | 184(78.30%) | 0.001 |
Diameter (maximal tumor) | 5.39 ± 3.14 | 7.01 ± 3.01 | < 0.001 |